Cargando…

Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2

The outbreak of a novel human coronavirus (SARS-CoV-2) has evolved into global health emergency, infecting hundreds of thousands of people worldwide. In an effort to find antiviral medications, many computational groups have pursued the 3C-like protease of the virus, also known as main protease (M(p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobrowski, Tesia, Alves, Vinicius M., Melo-Filho, Cleber C., Korn, Daniel, Auerbach, Scott, Schmitt, Charles, Muratov, Eugene N., Tropsha, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ChemRxiv 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252448/ https://www.ncbi.nlm.nih.gov/pubmed/32511287 http://dx.doi.org/10.26434/chemrxiv.12153594

Ejemplares similares

Learning from history: do not flatten the curve of antiviral research!
por: Bobrowski, Tesia, et al.
Publicado: (2020)

COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug - target protein associations from the CORD-19 corpus of scientific publications on COVID-19
por: Korn, Daniel, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
por: Korn, Daniel, et al.
Publicado: (2020)

COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database
por: Korn, Daniel, et al.
Publicado: (2020)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

In silico Selection and Experimental Validation of FDA-Approved Drugs as Anti-quorum Sensing Agents
por: Mellini, Marta, et al.
Publicado: (2019)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
por: Jiang, Pengfei, et al.
Publicado: (2014)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
por: Li, Mei, et al.
Publicado: (2022)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Computer-Aided Discovery of New Solubility-Enhancing Drug Delivery System
por: Mizera, Mikołaj, et al.
Publicado: (2020)

Correction: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
por: Jiang, Pengfei, et al.
Publicado: (2014)

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
por: Madrid, Peter B., et al.
Publicado: (2013)

New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
por: Stancu, Andreea Lucia, et al.
Publicado: (2014)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal
por: Mei, Yikun, et al.
Publicado: (2020)

Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
por: Tucker Edmister, Sara, et al.
Publicado: (2022)

Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury
por: Li, Haixia, et al.
Publicado: (2023)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization
por: Alves, Vinicius M., et al.
Publicado: (2015)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization
por: Amen, Triana, et al.
Publicado: (2016)

Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
por: Li, Bin, et al.
Publicado: (2014)

Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
por: Capuzzi, Stephen J., et al.
Publicado: (2017)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hghdedj7i1ct4t97lj09um065i